201 related articles for article (PubMed ID: 34560864)
21. Molecular docking and molecular dynamic studies: screening of phytochemicals against EGFR, HER2, estrogen and NF-KB receptors for their potential use in breast cancer.
Purawarga Matada GS; Dhiwar PS; Abbas N; Singh E; Ghara A; Das A; Bhargava SV
J Biomol Struct Dyn; 2022 Aug; 40(13):6183-6192. PubMed ID: 33525984
[TBL] [Abstract][Full Text] [Related]
22. Phytochemical profiling of bioactive compounds, anti-inflammatory and analgesic potentials of Habenaria digitata Lindl.: Molecular docking based synergistic effect of the identified compounds.
Mahnashi MH; Alyami BA; Alqahtani YS; Jan MS; Rashid U; Sadiq A; Alqarni AO
J Ethnopharmacol; 2021 Jun; 273():113976. PubMed ID: 33647424
[TBL] [Abstract][Full Text] [Related]
23. Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation.
Alos HC; Billones JB; Castillo AL; Vasquez RD
Daru; 2022 Dec; 30(2):273-288. PubMed ID: 35925539
[TBL] [Abstract][Full Text] [Related]
24. Phytochemical analysis of Daphne pontica L. stems with their pro-apoptotic properties against DU-145 and LNCaP prostate cancer cells.
Nikahd M; Aghaei M; Ali Z; Sajjadi SE; Khan IA; Ghanadian M
Daru; 2022 Jun; 30(1):85-101. PubMed ID: 35195873
[TBL] [Abstract][Full Text] [Related]
25. Chemical constituents with cytotoxic and anti-inflammatory activity in Hypericum sampsonii and the antitumor potential under the view of cancer-related inflammation.
Chen Q; Di L; Zhang Y; Li N
J Ethnopharmacol; 2020 Sep; 259():112948. PubMed ID: 32417427
[TBL] [Abstract][Full Text] [Related]
26. Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L.
Ayaz M; Junaid M; Ahmed J; Ullah F; Sadiq A; Ahmad S; Imran M
BMC Complement Altern Med; 2014 May; 14():145. PubMed ID: 24884823
[TBL] [Abstract][Full Text] [Related]
27. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
[TBL] [Abstract][Full Text] [Related]
28. Iodoquinazoline-derived VEGFR-2 and EGFR
Mohamed AA; El-Hddad SSA; Aljohani AKB; Khedr F; Alatawi OM; Keshek DE; Ahmed S; Alsulaimany M; Almadani SA; El-Adl K; Hanafy NS
Bioorg Chem; 2024 Feb; 143():107062. PubMed ID: 38150938
[TBL] [Abstract][Full Text] [Related]
29. Isolation, Characterization and Preliminary Cytotoxic and Antifungal Evaluations of Novel Lancifoliate Isolated from Methanol Extract of
Saadullah M; Asif M; A Ch B; Yaseen HS; Uzair M; Afzal K
Anticancer Agents Med Chem; 2020; 20(14):1664-1672. PubMed ID: 32329701
[TBL] [Abstract][Full Text] [Related]
30. A new sesquiterpenoid from the shoots of Iranian Daphne mucronata Royle with selective inhibition of STAT3 and Smad3/4 cancer-related signaling pathways.
Ghanadian M; Ali Z; Khan IA; Balachandran P; Nikahd M; Aghaei M; Mirzaei M; Sajjadi SE
Daru; 2020 Jun; 28(1):253-262. PubMed ID: 32248516
[TBL] [Abstract][Full Text] [Related]
31. Antitumor and anti-angiogenic potentials of isolated crude saponins and various fractions of Rumex hastatus D. Don.
Ahmad S; Ullah F; Ayaz M; Zeb A; Ullah F; Sadiq A
Biol Res; 2016 Mar; 49():18. PubMed ID: 26969307
[TBL] [Abstract][Full Text] [Related]
32.
Das SK; Deka SJ; Paul D; Gupta DD; Das TJ; Maravi DK; Tag H; Hui PK
J Biomol Struct Dyn; 2022 Sep; 40(15):6857-6867. PubMed ID: 33625319
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity and molecular docking analysis of racemolactone I, a new sesquiterpene lactone isolated from
Alam P; Tyagi R; Farah MA; Rehman MT; Hussain A; AlAjmi MF; Siddiqui NA; Al-Anazi KM; Amin S; Mujeeb M; Mir SR
Pharm Biol; 2021 Dec; 59(1):941-952. PubMed ID: 35294328
[TBL] [Abstract][Full Text] [Related]
34. Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.
M HR; Ghosh D; Banerjee R; Salimath BP
Pharm Biol; 2017 Dec; 55(1):1489-1499. PubMed ID: 28367666
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
Kadhim ZY; Alqaraghuli HGJ; Abd MT
Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
[TBL] [Abstract][Full Text] [Related]
36. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
[TBL] [Abstract][Full Text] [Related]
37. Antioxidant, Anti-Inflammatory and Cytotoxic Activities of
El-Hawary SS; El-Hefnawy HM; Osman SM; El-Raey MA; Mokhtar FA; Ibrahim HA
Anticancer Agents Med Chem; 2021; 21(18):2572-2582. PubMed ID: 34488594
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization, biological evaluation and molecular docking of a new quinazolinone-based derivative as a potent dual inhibitor for VEGFR-2 and EGFR tyrosine kinases.
Riadi Y; Alamri MA; Geesi MH; Anouar EH; Ouerghi O; Alabbas AB; Alossaimi MA; Altharawi A; Dehbi O; Alqahtani SM
J Biomol Struct Dyn; 2022 Sep; 40(15):6810-6816. PubMed ID: 33682611
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation.
Abdallah AE; Eissa SI; Al Ward MMS; Mabrouk RR; Mehany ABM; El-Zahabi MA
Bioorg Chem; 2021 Apr; 109():104695. PubMed ID: 33647743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
